reverse phase protein array Diverse Alterations Detected In Rare, Aggressive Uterine Cancer An integrated analysis of uterine carcinosarcomas uncovered a range of somatic mutations and shifts in transcription, methylation, and microRNA expression. Phosphoproteomic Data from I-SPY 2 IDs Potential New Marker of Patient Response to Neratinib Premium The marker has the potential to improve upon existing markers like HER2 and HR status while also expanding the population of patients considered for neratinib treatment. MD Anderson's Mills Building Cancer Proteome Atlas Using RPPA Data from 70,000-plus Patient Samples Premium Led by Gordon Mills, chair of systems biology at the University of Texas MD Anderson Cancer Center, a group of researchers is developing a database containing proteomic characterizations of thousands of cancer patient samples and cell lines. GMU Team Builds Phosphoproteomic-based Pathway Activation Profiles of NCI-60 Cancer Cell Lines Premium A team led by researchers at George Mason University has completed a phosphoproteomic analysis of the National Cancer Institute-60, a set of 60 human cancer cell lines. Theranostics Health to Launch HER Signaling Assay, Marking Firm's First Commercial Test Release Premium Theranostics Health this week announced the June launch of its first commercial test, a 14-protein assay for profiling activation of the HER signaling network. Sep 28, 2012 TCGA Breast Cancer Study Demonstrates Benefits of Integrating Genomic, Proteomic Data Premium Sep 14, 2012 MD Anderson RPPA Study Reveals New Potential Drug Targets in Small Cell Lung Cancer Premium Aug 31, 2012 Theranostics Looks for Med Fusion Deal to Aid in Clinical Validation, Payor Access Premium Jun 15, 2012 Theranostics Health to Launch Breast Cancer Dx in Early 2013, Raise $5M to $10M in Funding Premium Apr 6, 2012 MD Anderson-Led Team IDs Proteins Linked to HR-Positive Breast Cancer Prognosis Premium Nov 18, 2011 Phosphoproteomics Study Drives Phase I Trial Testing Pfizer ALK Inhibitor as Breast Cancer Therapy Premium Nov 11, 2011 Texas Universities Adding 10-Plus New Mass Spectrometers with $10.4M in CPRIT Funding Premium Sep 30, 2011 Duke Team IDs Warburg Effect and Linked Proteins as Possible Breast Cancer Predictor, Drug Target Premium Aug 2, 2011 MD Anderson Cancer Center Acquires Aushon Printer for Reverse Phase Protein Array Production Premium Nov 12, 2010 Duke Team Identifies Phosphoprotein Signatures That Could Predict Breast Cancer Risk Premium Aug 14, 2010 GMU's Petricoin Building Database That Details Activation in Cancer Protein Pathways Premium Jan 22, 2010 Liotta, Petricoin Using Protein Array Technology to Test Gleevec for Colorectal Cancer Premium Jan 20, 2010 GMU Developing Proteomic Profile to Personalize Gleevec Treatment for CRC; Novartis Provides Funding Premium Breaking News Children With Autism May Have Underdeveloped Gut Microbiomes, Metagenomic Analysis Finds Kiromic BioPharma Acquires InSilico Solutions Bio-Rad Laboratories, 10x Genomics Settle IP Lawsuits, Sign Global Cross-Licensing Agreement Scope Fluidics Obtains CE Mark for PCR-Based SARS-CoV-2 Panel MeMed COVID-19 Prognostic Test Receives CE Mark ERS Genomics Licenses CRISPR IP to Japan SLC The Scan Dropped Charges The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal. More Kids The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children. PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more. Purnell Choppin Dies Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.